Synthetic Genomics' Exxon Biofuel Pact Worth Up to $300M | GenomeWeb

NEW YORK (GenomeWeb News) –Synthetic Genomics has struck a biofuel research and development agreement with ExxonMobil Research and Engineering Company that could bring in up to $300 million for the genomics firm, the companies said today.

The agreement to develop biofuel from photosynthetic algae that would be compatible with gasoline and diesel fuels could bring in $300 million to SGI if certain milestones are met. Exxon plans to spend up to another $300 million internally to support the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.